웨어러블 로봇 외골격 시장 규모, 점유율, 성장 및 세계 산업 분석 : 기술 유형별, 용도별, 신체 부위별, 구동 기술별, 최종사용자별, 지역별 인사이트와 예측(2026-2034년)

Growth Factors of wearable robotic exoskeleton Market

The global wearable robotic exoskeleton market has witnessed remarkable growth over the past decade, driven by technological advancements, increasing rehabilitation needs, and heightened focus on workplace safety. According to Fortune Business Insights, the market was valued at USD 2.49 billion in 2025, is projected to reach USD 3.52 billion in 2026, and expected to surge to USD 64.23 billion by 2034, exhibiting a CAGR of 43.7% during the forecast period. North America led the market in 2025 with a 38.7% share, fueled by strong investments in healthcare, industrial, and defense applications, as well as the presence of leading exoskeleton manufacturers.

The growing adoption of powered exoskeletons, particularly in healthcare, manufacturing, and defense sectors, has been a major driver of market expansion. These systems provide enhanced mobility, strength, and endurance for users, making them ideal for rehabilitation, industrial tasks, and military operations. Technological innovations, especially in AI, sensors, and battery efficiency, are further boosting adoption across multiple sectors.

Market Dynamics

Drivers

The rising need for rehabilitation solutions for individuals recovering from injuries, surgeries, or neurological disorders is a key growth driver. Wearable robotic exoskeletons provide support during physical therapy, aiding in the restoration of motor functions and enhancing patient independence. Technological advancements in sensors, artificial intelligence, and materials have increased comfort and adaptability, making exoskeletons effective in clinical and healthcare settings. Additionally, industrial and defense sectors are adopting exoskeletons to reduce worker fatigue, prevent injuries, and improve physical performance, creating significant growth opportunities.

Restraints

High costs and limited insurance coverage hinder widespread adoption. Advanced exoskeletons require substantial investment in development, materials, and maintenance. Many insurance providers consider them experimental or luxury devices, limiting accessibility, particularly in low- and middle-income regions. Addressing affordability and reimbursement issues remains critical for market expansion.

Opportunities

Emerging industrial and military applications present new growth avenues. Exoskeletons are increasingly used for heavy lifting, repetitive tasks, and load-carrying support in manufacturing, logistics, and defense. Technological improvements make these devices lighter, more robust, and adaptable to different environments, enabling broader adoption beyond healthcare.

Market Trends

Integration of AI and advanced sensors allows exoskeletons to learn and adapt to user movements, providing personalized support. Pressure, motion, and biofeedback sensors improve precision and usability, enhancing recovery outcomes in rehabilitation and increasing efficiency in industrial settings.

Segmentation Analysis

By Technology Type

• Powered exoskeletons dominated the market in 2026 with 86.36% share, offering motorized assistance for enhanced mobility.
• Passive exoskeletons, relying on mechanical support, serve as affordable alternatives but hold a smaller market share.

By Application

• Assistive exoskeletons hold the highest market share, helping individuals with mobility challenges regain independence.
• Rehabilitation exoskeletons captured 38.64% in 2026, aiding post-injury recovery.
• Body part support exoskeletons show the fastest CAGR of 52.26% (2025-2032), particularly in industrial ergonomics.
• Sports applications remain niche with smaller adoption rates.

By Body Part

• Upper body exoskeletons dominate with 45.74% share in 2026 and the highest CAGR of 47.82%, mainly for industrial and manufacturing use.
• Lower body exoskeletons held 38% in 2025, used predominantly for rehabilitation.
• Full body exoskeletons remain niche due to high costs and specialized applications.

By Actuation Technology

• Electric exoskeletons lead with 65.63% share in 2025, offering precise and programmable assistance.
• Hydraulic systems are ideal for heavy-duty operations, projected to grow at CAGR of 40.95% (2025-2032).
• Fully mechanical and pneumatic/hybrid systems remain niche segments.

By End User

• Healthcare is the largest end-user segment, holding 39% share in 2025, driven by rehabilitation and mobility assistance.
• Manufacturing adoption reduces worker fatigue and injury risk.
• Defense and aerospace exhibit the highest CAGR of 48.85% (2025-2032) due to investments in soldier performance.
• Other sectors include commercial, sports, and entertainment, which remain niche.

Regional Insights

• North America: Market valued at USD 2.49 billion in 2025 and USD 3.52 billion in 2026, led by U.S. healthcare and defense adoption.
• Europe: Second-largest, projected USD 1.09 billion in 2026, driven by Germany, France, and U.K., with robust industrial and rehabilitation adoption.
• Asia Pacific: Estimated USD 0.99 billion in 2026, led by China (USD 0.42 billion) and Japan (USD 0.22 billion), fueled by aging populations and industrial needs.
• South America: Smaller market, valued at USD 0.04 billion in 2025, gradually expanding in Brazil and Argentina.
• Middle East & Africa: Nascent market, GCC valued at USD 0.01 billion in 2025, with growing interest in industrial and healthcare applications.

Competitive Landscape

The market is highly competitive, with key players focusing on innovation, R&D, and strategic collaborations. Prominent companies include:

• Ekso Bionics (U.S.)
• Ottobock (Germany)
• CYBERDYNE, INC. (Japan)
• Fourier Intelligence (Singapore)
• ReWalk Robotics (U.S.)
• Auxivo AG (Switzerland)
• Parker Hannifin Corporation (U.S.)

Recent developments include industrial exoskeletons in Germany, software upgrades for rehabilitation in the U.S., and collaborations for military applications in India, emphasizing innovation and sector expansion.

Conclusion

The wearable robotic exoskeleton market is projected to grow from USD 2.49 billion in 2025 to USD 64.23 billion by 2034, with North America leading regionally. Powered exoskeletons, assistive applications, upper-body devices, and electric actuation technologies dominate the market. Growth is driven by rehabilitation needs, industrial and military adoption, AI integration, and technological innovation. Despite high costs and limited insurance coverage, expanding applications across healthcare, industrial, and defense sectors provide long-term growth opportunities, positioning wearable robotic exoskeletons as a transformative solution in mobility, safety, and productivity worldwide.

Segmentation By Technology Type, By Application, By Body Part, By Actuation Technology, By End User, and By Region

By Technology Type * Powered

• Passive

By Application * Rehabilitation

• Assistive
• Body Parts Support
• Sports

By Body Part * Lower Body

• Upper Body
• Full Body

By Actuation Technology * Electric

• Hydraulic
• Fully Mechanical
• Others (Pneumatic,etc.)

By End User * Healthcare

• Manufacturing
• Defense & Aerospace
• Commercial

By Region * North America (By Technology Type, By Application, By Body Part, By Actuation Technology, By End User, By Country)

• U.S. (By End User)
• Canada (By End User)
• Mexico (By End User)
• Europe (By Technology Type, By Application, By Body Part, By Actuation Technology, By End User, By Country)
  • Germany (By End User)
  • U.K. (By End User)
  • France (By End User)
  • Italy (By End User)
  • Rest of Europe
• Asia Pacific (By Technology Type, By Application, By Body Part, By Actuation Technology, By End User, By Country)
  • China (By End User)
  • Japan (By End User)
  • South Korea (By End User)
  • India (By End User)
  • Rest of Asia Pacific
• South America (By Technology Type, By Application, By Body Part, By Actuation Technology, By End User, By Country)
  • Brazil (By End User)
  • Argentina (By End User)
  • Rest of South America
• Middle East & Africa (By Technology Type, By Application, By Body Part, By Actuation Technology, By End User, By Country)
  • GCC (By End User)
  • South Africa (By End User)
  • Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Definition, By Segment
• 1.2. Research Methodology/Approach
• 1.3. Data Sources

2. Executive Summary

3. Market Dynamics

• 3.1. Macro and Micro Economic Indicators
• 3.2. Drivers, Restraints, Opportunities and Trends

4. Competition Landscape

• 4.1. Business Strategies Adopted by Key Players
• 4.2. Consolidated SWOT Analysis of Key Players
• 4.3. Global Wearable Robotic Exoskeleton Machine Key Players (Top 3-5) Market Share/Ranking, 2025

5. Global Wearable Robotic Exoskeleton Market Size Estimates and Forecasts (Quantitative Data), By Segments, 2021-2034

• 5.1. Key Findings
• 5.2. By Technology Type (USD)
  • 5.2.1. Powered
  • 5.2.2. Passive
• 5.3. By Application (USD)
  • 5.3.1. Rehabilitation
  • 5.3.2. Assistive
  • 5.3.3. Body Parts Support
  • 5.3.4. Sports
• 5.4. By Body Part (USD)
  • 5.4.1. Lower Body
  • 5.4.2. Upper Body
  • 5.4.3. Full Body
• 5.5. By Actuation Technology (USD)
  • 5.5.1. Electric
  • 5.5.2. Hydraulic
  • 5.5.3. Fully Mechanical
  • 5.5.4. Others
• 5.6. By End User (USD)
  • 5.6.1. Healthcare
  • 5.6.2. Manufacturing
  • 5.6.3. Defense & Aerospace
  • 5.6.4. Others (Commercial, etc.)
• 5.7. By Region (USD)
  • 5.7.1. North America
  • 5.7.2. Europe
  • 5.7.3. Asia Pacific
  • 5.7.4. South America
  • 5.7.5. Middle East & Africa

6. North America Wearable Robotic Exoskeleton Market Size Estimates and Forecasts (Quantitative Data), By Segments, 2021-2034

• 6.1. Key Findings
• 6.2. By Technology Type (USD)
  • 6.2.1. Powered
  • 6.2.2. Passive
• 6.3. By Application (USD)
  • 6.3.1. Rehabilitation
  • 6.3.2. Assistive
  • 6.3.3. Body Parts Support
  • 6.3.4. Sports
• 6.4. By Body Part (USD)
  • 6.4.1. Lower Body
  • 6.4.2. Upper Body
  • 6.4.3. Full Body
• 6.5. By Actuation Technology (USD)
  • 6.5.1. Electric
  • 6.5.2. Hydraulic
  • 6.5.3. Fully Mechanical
  • 6.5.4. Others
• 6.6. By End User (USD)
  • 6.6.1. Healthcare
  • 6.6.2. Manufacturing
  • 6.6.3. Defense & Aerospace
  • 6.6.4. Others (Commercial, etc.)
• 6.7. By Country (USD)
  • 6.7.1. U.S.
    • 6.7.1.1. By End User (USD)
  • 6.7.2. Canada
    • 6.7.2.1. By End User (USD)
  • 6.7.3. Mexico
    • 6.7.3.1. By End User (USD)

7. Europe Wearable Robotic Exoskeleton Market Size Estimates and Forecasts (Quantitative Data), By Segments, 2021-2034

• 7.1. Key Findings
• 7.2. By Technology Type (USD)
  • 7.2.1. Powered
  • 7.2.2. Passive
• 7.3. By Application (USD)
  • 7.3.1. Rehabilitation
  • 7.3.2. Assistive
  • 7.3.3. Body Parts Support
  • 7.3.4. Sports
• 7.4. By Body Part (USD)
  • 7.4.1. Lower Body
  • 7.4.2. Upper Body
  • 7.4.3. Full Body
• 7.5. By Actuation Technology (USD)
  • 7.5.1. Electric
  • 7.5.2. Hydraulic
  • 7.5.3. Fully Mechanical
  • 7.5.4. Others
• 7.6. By End User (USD)
  • 7.6.1. Healthcare
  • 7.6.2. Manufacturing
  • 7.6.3. Defense & Aerospace
  • 7.6.4. Others (Commercial, etc.)
• 7.7. By Country (USD)
  • 7.7.1. U.K.
    • 7.7.1.1. By End User (USD)
  • 7.7.2. Germany
    • 7.7.2.1. By End User (USD)
  • 7.7.3. France
    • 7.7.3.1. By End User (USD)
  • 7.7.4. Italy
    • 7.7.4.1. By End User (USD)
  • 7.7.5. Rest of Europe

8. Asia Pacific Wearable Robotic Exoskeleton Market Size Estimates and Forecasts (Quantitative Data), By Segments, 2021-2034

• 8.1. Key Findings
• 8.2. By Technology Type (USD)
  • 8.2.1. Powered
  • 8.2.2. Passive
• 8.3. By Application (USD)
  • 8.3.1. Rehabilitation
  • 8.3.2. Assistive
  • 8.3.3. Body Parts Support
  • 8.3.4. Sports
• 8.4. By Body Part (USD)
  • 8.4.1. Lower Body
  • 8.4.2. Upper Body
  • 8.4.3. Full Body
• 8.5. By Actuation Technology (USD)
  • 8.5.1. Electric
  • 8.5.2. Hydraulic
  • 8.5.3. Fully Mechanical
  • 8.5.4. Others
• 8.6. By End User (USD)
  • 8.6.1. Healthcare
  • 8.6.2. Manufacturing
  • 8.6.3. Defense & Aerospace
  • 8.6.4. Others (Commercial, etc.)
• 8.7. By Country (USD)
  • 8.7.1. China
    • 8.7.1.1. By End User (USD)
  • 8.7.2. Japan
    • 8.7.2.1. By End User (USD)
  • 8.7.3. India
    • 8.7.3.1. By End User (USD)
  • 8.7.4. South Korea
    • 8.7.4.1. By End User (USD)
  • 8.7.5. Rest of Asia Pacific

9. South America Wearable Robotic Exoskeleton Market Size Estimates and Forecasts (Quantitative Data), By Segments, 2021-2034

• 9.1. Key Findings
• 9.2. By Technology Type (USD)
  • 9.2.1. Powered
  • 9.2.2. Passive
• 9.3. By Application (USD)
  • 9.3.1. Rehabilitation
  • 9.3.2. Assistive
  • 9.3.3. Body Parts Support
  • 9.3.4. Sports
• 9.4. By Body Part (USD)
  • 9.4.1. Lower Body
  • 9.4.2. Upper Body
  • 9.4.3. Full Body
• 9.5. By Actuation Technology (USD)
  • 9.5.1. Electric
  • 9.5.2. Hydraulic
  • 9.5.3. Fully Mechanical
  • 9.5.4. Others
• 9.6. By End User (USD)
  • 9.6.1. Healthcare
  • 9.6.2. Manufacturing
  • 9.6.3. Defense & Aerospace
  • 9.6.4. Others (Commercial, etc.)
• 9.7. By Country (USD)
  • 9.7.1. Brazil
    • 9.7.1.1. By End User (USD)
  • 9.7.2. Argentina
    • 9.7.2.1. By End User (USD)
  • 9.7.3. Rest of South America

10. Middle East & Africa Wearable Robotic Exoskeleton Market Size Estimates and Forecasts (Quantitative Data), By Segments, 2021-2034

• 10.1. Key Findings
• 10.2. By Technology Type (USD)
  • 10.2.1. Powered
  • 10.2.2. Passive
• 10.3. By Application (USD)
  • 10.3.1. Rehabilitation
  • 10.3.2. Assistive
  • 10.3.3. Body Parts Support
  • 10.3.4. Sports
• 10.4. By Body Part (USD)
  • 10.4.1. Lower Body
  • 10.4.2. Upper Body
  • 10.4.3. Full Body
• 10.5. By Actuation Technology (USD)
  • 10.5.1. Electric
  • 10.5.2. Hydraulic
  • 10.5.3. Fully Mechanical
  • 10.5.4. Others
• 10.6. By End User (USD)
  • 10.6.1. Healthcare
  • 10.6.2. Manufacturing
  • 10.6.3. Defense & Aerospace
  • 10.6.4. Others (Commercial, etc.)
• 10.7. By Country (USD)
  • 10.7.1. GCC
    • 10.7.1.1. By End User (USD)
  • 10.7.2. South Africa
    • 10.7.2.1. By End User (USD)
  • 10.7.3. Rest of Middle East & Africa

11. Company Profiles for Top 10 Players (Based on data availability in public domain and/or on paid databases)

• 11.1. Rex Bionics Pty Ltd
  • 11.1.1. Overview
    • 11.1.1.1. Key Management
    • 11.1.1.2. Headquarters
    • 11.1.1.3. Offerings/Business Segments
  • 11.1.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.1.2.1. Employee Size
    • 11.1.2.2. Past and Current Revenue
    • 11.1.2.3. Geographical Share
    • 11.1.2.4. Business Segment Share
    • 11.1.2.5. Recent Developments
• 11.2. DIH Medical
  • 11.2.1. Overview
    • 11.2.1.1. Key Management
    • 11.2.1.2. Headquarters
    • 11.2.1.3. Offerings/Business Segments
  • 11.2.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.2.2.1. Employee Size
    • 11.2.2.2. Past and Current Revenue
    • 11.2.2.3. Geographical Share
    • 11.2.2.4. Business Segment Share
    • 11.2.2.5. Recent Developments
• 11.3. Bionik Laboratories Corp.
  • 11.3.1. Overview
    • 11.3.1.1. Key Management
    • 11.3.1.2. Headquarters
    • 11.3.1.3. Offerings/Business Segments
  • 11.3.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.3.2.1. Employee Size
    • 11.3.2.2. Past and Current Revenue
    • 11.3.2.3. Geographical Share
    • 11.3.2.4. Business Segment Share
    • 11.3.2.5. Recent Developments
• 11.4. Ottobock
  • 11.4.1. Overview
    • 11.4.1.1. Key Management
    • 11.4.1.2. Headquarters
    • 11.4.1.3. Offerings/Business Segments
  • 11.4.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.4.2.1. Employee Size
    • 11.4.2.2. Past and Current Revenue
    • 11.4.2.3. Geographical Share
    • 11.4.2.4. Business Segment Share
    • 11.4.2.5. Recent Developments
• 11.5. Cyberdyne Inc.
  • 11.5.1. Overview
    • 11.5.1.1. Key Management
    • 11.5.1.2. Headquarters
    • 11.5.1.3. Offerings/Business Segments
  • 11.5.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.5.2.1. Employee Size
    • 11.5.2.2. Past and Current Revenue
    • 11.5.2.3. Geographical Share
    • 11.5.2.4. Business Segment Share
    • 11.5.2.5. Recent Developments
• 11.6. Parker Hannifin Corporation
  • 11.6.1. Overview
    • 11.6.1.1. Key Management
    • 11.6.1.2. Headquarters
    • 11.6.1.3. Offerings/Business Segments
  • 11.6.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.6.2.1. Employee Size
    • 11.6.2.2. Past and Current Revenue
    • 11.6.2.3. Geographical Share
    • 11.6.2.4. Business Segment Share
    • 11.6.2.5. Recent Developments
• 11.7. Lockheed Martin
  • 11.7.1. Overview
    • 11.7.1.1. Key Management
    • 11.7.1.2. Headquarters
    • 11.7.1.3. Offerings/Business Segments
  • 11.7.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.7.2.1. Employee Size
    • 11.7.2.2. Past and Current Revenue
    • 11.7.2.3. Geographical Share
    • 11.7.2.4. Business Segment Share
    • 11.7.2.5. Recent Developments
• 11.8. ReWalk Robotics Inc.
  • 11.8.1. Overview
    • 11.8.1.1. Key Management
    • 11.8.1.2. Headquarters
    • 11.8.1.3. Offerings/Business Segments
  • 11.8.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.8.2.1. Employee Size
    • 11.8.2.2. Past and Current Revenue
    • 11.8.2.3. Geographical Share
    • 11.8.2.4. Business Segment Share
    • 11.8.2.5. Recent Developments
• 11.9. Ekso Bionics
  • 11.9.1. Overview
    • 11.9.1.1. Key Management
    • 11.9.1.2. Headquarters
    • 11.9.1.3. Offerings/Business Segments
  • 11.9.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.9.2.1. Employee Size
    • 11.9.2.2. Past and Current Revenue
    • 11.9.2.3. Geographical Share
    • 11.9.2.4. Business Segment Share
    • 11.9.2.5. Recent Developments
• 11.10. Sarcos Corporation
  • 11.10.1. Overview
    • 11.10.1.1. Key Management
    • 11.10.1.2. Headquarters
    • 11.10.1.3. Offerings/Business Segments
  • 11.10.2. Key Details (Key details are consolidated data and not product/service specific)
    • 11.10.2.1. Employee Size
    • 11.10.2.2. Past and Current Revenue
    • 11.10.2.3. Geographical Share
    • 11.10.2.4. Business Segment Share
    • 11.10.2.5. Recent Developments

12. Key Takeaways